Table 3.

Hemostatic Features of Patients With ALI/ALF According to 21‐Day Outcome: Transplant‐Free Survivors and Non‐Transplant‐Free Survivors (Death or Liver Transplantation)

	Number Analyzed	21‐Day TFS (n = 483)	Number analyzed	Non‐21‐Day TFS (n = 193)
VWF (%) (95% CI)*	480	403.6 (387.1‐420.0)	192	559.0 (521.5‐596.6)
ADAMTS13 (%) (95% CI) †	478	22.5 (20.3‐24.6)	192	17.8 (15.0‐20.7)
ETP (nM IIa*min) (95% CI)	471	543.7 (511.8‐575.6)	185	566.9 (498.9‐635.0)
CLT > 180 minutes (%) (95% CI)	460	65.7 (61.3‐70.0)	181	61.3 (54.2‐68.5)

Data are presented as mean (95% CI) or percentage (95% CI).

^* P < 0.001.

^† P < 0.05.

Abbreviation: TFS, transplant‐free survivor.